Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 38 min ago
PreprintCC BY-NC-NDbioRxiv

Signed Dopaminergic Asymmetry Tracks Contralateral Motor Laterality in Parkinsons Disease

  1. 1U Texas

Abstract

Parkinson's disease is asymmetric, but representations that collapse left--right measurements discard that direction. We separated overall dopamine-transporter availability from hemispheric distribution: mean putamen specific-binding ratio (SBR) indexed overall DaT signal, whereas signed asymmetry retained which hemisphere was relatively more affected. Signed asymmetry aligned with contralateral MDS-UPDRS Part III laterality in PPMI (n=1,367; r=0.676) and S4 (n=56; r=0.551). In 1,204 PPMI landmarks, each 0.1 asymmetry corresponded to a 0.0507 increase in 12-month laterality (95\% CI 0.0387--0.0626); held-out R2 improved 0.0176 over non-directional imaging but was uncertain under a bounded link. Exploratory imaging--clinical disagreement marked lower side persistence (OR=0.491 per IQR-standardized unit; 0.297--0.711). Signed direction therefore distinguishes mirror-image and conflicting dopaminergic--motor states erased by mean-only summaries. This is a reproducible biological coordinate, not global progression, treatment benefit or clinical utility.

Related

  1. Dopaminergic Medication Improves Force Control and Modifies Motor Unit Activity During the Steadiest and Least Steady Periods in Parkinsons Disease
    P. Alaei, A. Holobar, D. J. Wile +1
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  2. Paraquat Inhalation Produces Male-Biased Dopaminergic Neuron Loss and Motor Deficits in Mice: Relevance to Parkinsons Disease
    P. J. Reina-Gonzalez, J. R. Boos, A. Abu-Salah +8
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  3. Pallidal beta oscillations underlying locomotor adaptation in Parkinsons disease
    J. T. Choi, A. Gurrala, D. D. Wang +2
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
  4. Intrinsic dimensionality of deep learning representations reveals cell death-associated heterogeneity in Parkinsons disease iPSC-derived neurons
    M. L. Choi, S. Kang, J. Park
    bioRxivPreprintAll rights reservedFull textCell biologybioRxiv
  5. Targeting microglial P2Y12-receptor signalling attenuates neurodegeneration in experimental Parkinsons disease
    A. Iring, D. J. Kiss, M. Baranyi +9
    bioRxivPreprintAll rights reservedFull textNeurosciencebioRxiv
BibTeX
@misc{tirhekar2026signed,
  title = {{Signed Dopaminergic Asymmetry Tracks Contralateral Motor Laterality in Parkinsons Disease}},
  author = {H. Tirhekar and P. Yadav and C. Bajaj},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.23.753983},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.23.753983v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Signed Dopaminergic Asymmetry Tracks Contralateral Motor Laterality in Parkinsons Disease
AU  - H. Tirhekar
AU  - P. Yadav
AU  - C. Bajaj
PY  - 2026
DA  - 2026/09/23
PB  - bioRxiv
DO  - 10.64898/2026.09.23.753983
UR  - https://www.biorxiv.org/content/10.64898/2026.09.23.753983v1
AB  - Parkinson's disease is asymmetric, but representations that collapse left--right measurements discard that direction. We separated overall dopamine-transporter availability from hemispheric distribution: mean putamen specific-binding ratio (SBR) indexed overall DaT signal, whereas signed asymmetry retained which hemisphere was relatively more affected. Signed asymmetry aligned with contralateral MDS-UPDRS Part III laterality in PPMI (n=1,367; r=0.676) and S4 (n=56; r=0.551). In 1,204 PPMI landmarks, each 0.1 asymmetry corresponded to a 0.0507 increase in 12-month laterality (95\% CI 0.0387--0.0626); held-out R^2 improved 0.0176 over non-directional imaging but was uncertain under a bounded link. Exploratory imaging--clinical disagreement marked lower side persistence (OR=0.491 per IQR-standardized unit; 0.297--0.711). Signed direction therefore distinguishes mirror-image and conflicting dopaminergic--motor states erased by mean-only summaries. This is a reproducible biological coordinate, not global progression, treatment benefit or clinical utility.
ER  -